Navigation Links
SmallCapSentinel.com Releases Report for Investors of Medical Device Companies SENO, STXS, EVVV, ANGO, THOR, and CPTS
Date:6/10/2009

LAS VEGAS, June 10 /PRNewswire/ -- SmallCapSentinel.com announces the availability of the report "A Growing Body of Evidence" related to the medical device industry featuring SenoRx, Inc. (NasdaqGM: SENO) and of interest to investors of Stereotaxis Inc. (NasdaqGM: STXS), ev3 Inc. (NasdaqGS: EVVV), AngioDynamics Inc. (NasdaqGS: ANGO), Thoratec Corp. (NasdaqGS: THOR) and Conceptus Inc. (NasdaqGM: CPTS).

To read the article "A Growing Body of Evidence" visit:

http://www.smallcapsentinel.com/SENO6-7

From the report: SenoRx, Inc. believes that a breast cancer patient treated with its Contura(TM) Multi-Lumen Balloon (MLB) receives a more targeted dose of radiation while minimizing radiation to healthy surrounding tissue such as the skin and ribs than those treated with whole breast irradiation or with a single-lumen balloon. A growing and compelling body of scientific data suggests SenoRx is right. Over the past few months data has been rolling in from experts and opinion leaders, research partners and clinical sites. A consensus is forming and the future for Contura MLB (and SenoRx) seems brighter than ever.

For an Integrity Media profile of SenoRx please visit: www.IntegrityIR.com/SENO

To view the related article, "Innovation and Speed to Market" visit:

http://integrityir.com/SENOSCS1

Register to receive these reports directly at: www.SmallCapSentinel.com/register

Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results. Small Cap Sentinel is property of Integrity Media Inc. (IMI). IMI provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience. The subject companies haven't always approved the statements made in this report. This report is neither a solicitation to buy nor offer to sell securities and is for information purposes only and shouldn't be used as basis for investment decisions. IMI isn't an investment advisor, analyst or licensed broker dealer and this report isn't investment advice. IMI has been paid thirty-thousand dollars by SenoRx for this report and other services to be performed over the remainder of the calendar year. Paid reports constitute a conflict of interest as to IMI's ability to remain objective in communication regarding subject companies. S.Convery CRD #2495267.

    Contact:
    Kurt Divich, Editor
    Integrity Media Inc.
    702-396-1000


'/>"/>
SOURCE Integrity Media
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
2. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
3. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
4. Verdict One Releases Directory of Board Certified Attorneys for Consumers
5. Academy releases emergency preparedness tools to enable millions more people to shelter in place
6. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
7. MITEM Releases Blue Iris eLaborate 8.6
8. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
9. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
10. URAC Releases Issue Briefs Examining Stakeholders Views of Care Coordination Along the Healthcare Continuum
11. Cardiac Science Releases New Cardiac Rehabilitation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve ... engagement.” The patient is doing more than filling out a survey; in many cases ... an increasing emphasis in health care and research on the importance of active engagement ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical ... the primary prevention of cardiovascular diseases during the 15th Annual Women’s Health ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... AVACEN Medical , Inc. (AVACEN) announced that Frost & ... Innovation Award for Its fibromyalgia pain management device. The ... market research by Frost & Sullivan,s industry experts. ... product, the AVACEN 100, offers a safe and effective solution ... ...
(Date:10/12/2017)... 12, 2017 West Pharmaceutical Services, Inc. ... for injectable drug administration, today announced that it will ... on Thursday, October 26, 2017, and will follow with ... expectations at 9:00 a.m. Eastern Time. To participate on ... The conference ID is 94093362. ...
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
Breaking Medicine Technology: